Recent Episodes
January 22, 2025
In the News.. Dexcom 15-day sensor update, TrialNet milestone, Beta Bionic IPO, and more!
It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: Dexcom updates investors on its 15-day sensor, TrialNet marks a big anniversary, Beta Bionics goes public, NFL fans support Mark Andrews and much more!
January 22, 2025
DiabeticU: On a mission to build better support for people with type 2
Today on Diabetes Connections Type 2: Like a lot of people diagnosed with diabetes, Matthew Tremellen didn’t feel like he got enough information, fast enough from his health care team. So he decided to build a tool to help. We’re talking to Matthew about DiabeticU, a new platform that aims to make learning about – and managing – type 2 easier.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
January 10, 2025
In the News... BIG beta cell transplant news, a new pump team-up, FDA moves on GLP-1 compounds, and more!
It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: Sana announces beta cell transplantation without the need for immunosuppresion drugs, Modular Medical teams up with Nudge BG for a brand new completely closed-loop system, the FDA moves forward to crack down on compounded Ozempic and Mounjaro, Dexcom and Abbott bury the legal hatchett for a while, and more.
December 20, 2024
In the News... Inhaled Insulin Studied for Kids, Dexcom Launches AI, App for Driving & T1D, and more!
It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: Mannkind releases info about it’s Afrezza pediatric studies, Dexcom launches AI tech with Stelo, Health Canada approves Tandem/Dexcom G7, diabetes drug may help sleep apnea, an app in development to help drivers with T1D and more!
December 6, 2024
In the News.. Defining T1D stages, InsuJet approval, T2D dementia risk and more!
It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: A push to change the defined stages of T1D, InsuJet is approved in Canada, new study linked T2D and dementia, new drug looked at to prevent hypoglycemia, big honors for a T1D author and more!
We have a monthly newsletter! Sign up today (no spam we promise)
November 27, 2024
Diabetes Digital: Bridging the gaps in type 2 care
Finding good diabetes info can be tough – there aren’t enough endos and even if you have a great GP, a lot of information can fall through the cracks. More and more digital services and telehealth options are trying to fill the void here – but of course you want to be careful about quality – and cost. I’m talking to two diabetes educators who want to change how we look at diabetes care, while working inside the complicated system of insurance.
We have a monthly newsletter! Sign up today (no spam we promise)
November 15, 2024
In the News... World Diabetes Day, Free T1D Care(?!), More Mounjaro info, New pump system, and more!
It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: World Diabetes Day roundup, existing drugs examined for T1D prevention, Blue Circle Health expands its novel T1D care model, Mounjaro studied further, Canada approves a new pumps system, and tragedy in the diabetes community.
We have a monthly newsletter! Sign up today (no spam we promise)
November 2, 2024
In the News... Omnipod 5 iPhone update, Libre & Dexcom news, overnight insulin pump... and more!
It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: iPhone control for Omnipod 5 rolls out, Libre is approved for use in CT scans and MRIs, Dexcom files for 15 day wear, Luna nighttime pump goes to trial, iLet cell trials move forward and more!
We have a monthly newsletter! Sign up today (no spam we promise)
October 11, 2024
In the News... Hurricane aid, Medtronic safety warning, Mounjaro supply update, stem cell T1D success... and more!
It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: Hurricane aid for people with diabetes, Medtronic safety warning, stem cell updates for type 1, new study about teens and young adults with type 1, and Ryan Reed returns to racing.
We have a monthly newsletter! Sign up today (no spam we promise)
September 27, 2024
In the News... Insulin price lawsuit, new CGM approved, diabetes camp scholarships... and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The FTC sues PBMs over insulin pricing, a new CGM is approved in Europe, more news about GLP-1s but some research says it may not work as well for one population, diabetes camps are invited to apply for grants, and more!
We have a monthly newsletter! Sign up today (no spam we promise)
September 25, 2024
Omnipod 5 Brings Automated Insulin Delivery to Type 2 Diabetes
Automated insulin delivery has been an incredible advancement for insulin pumps. Now, for the first time, the FDA has approved a system for people with type 2. It’s called Omnipod 5. We’re going to talk about how it works, who it helps, and what the company found in their studies of people who use it.
My guest this week is Insulet Medical Director Dr. Trang Ly, truly one of the pioneers of studying and innovating around automated insulin delivery – or AID – systems.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
We have a monthly newsletter! Sign up today (no spam we promise)
September 17, 2024
CGM Without a Prescription: Stelo & the Future of Diabetes Care with Dexcom's Jake Leach
For the first time, you can buy a continuous glucose monitor over the counter, no prescription needed. This summer we went from no CGMs available this way, to now having two. This week we’re talking about the Dexcom Stelo with the company’s COO Jake Leach. We’ll go through the features, the price, how to order and what you should know before you start a CGM.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
We have a monthly newsletter! Sign up today (no spam we promise)
September 13, 2024
In the News... CGM in space, diet and type 1 diabetes study, GLP-1 gel in development, and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom CGM is worn in space, two over-the-counter CGMs are now available, a large new study looks at potential dietary causes of type 1, and researchers are looking at a gel version of GLP-1 medications.
We have a monthly newsletter! Sign up today (no spam we promise)
August 30, 2024
In the News.. Omnipod 5 approved for type 2, bright light at night diabetes link, Zepbound price cut, and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The FDA approved Omnipod 5 for people with type 2 who use insulin, Dexcom’s Stelo, the first over the counter CGM, is now on sale. more evidence that bright light at night may increase the risk of diabetes, a price cut for Zepbound, and more!
We have a monthly newsletter! Sign up today (no spam we promise)
August 16, 2024
In the News... Weekly basal + semaglutide, liver targeted insulin, Lance Bass educates about LADA, and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A weekly basal plus semaglutide is in the works, but not for the US right now, Tandem updates it’s app recall, liver targeted insulin study, a weird walking story, and Lance Bass educates about LADA.
We have a monthly newsletter! Sign up today (no spam we promise)
July 31, 2024
Preventing kidney complications: Information over fear
Talking about any possible complications from diabetes can be scary – and most of us only think of kidney issues in the worst possible way: transplant and dialysis. But there’s a lot you can do to stay healthy and there’s news from just this summer about how new medications are making a big difference to reduce your risk.
My guests this week are Dr. Bob Gabbay, Chief Scientific and Medical Officer, American Diabetes Association and Dr. Jeff Giullian, Chief Medical Officer of DaVita. DaVita Kidney Care is a leading provider of kidney care in the United States.
We have a monthly newsletter! Sign up today (no spam we promise)
July 19, 2024
In the News...Does insulin use differ by gender? Diabetes & Covid update, fully implantable CGM studied, and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study looks at insulin needs in men vs women, updates on stem cell transplants and a new look at COVID 19 and T1D plus a fully implantable CGM is announced. We’ll also tell you about a T1D athlete drafted to the MLB. Lots more in this week’s episode, full transcipt below.
We have a monthly newsletter! Sign up today (no spam we promise)
July 10, 2024
What is EPI? The link to diabetes (and whether you're at risk)
Dana Lewis was diagnosed with something called EPI – exocrine pancreatic insufficiency a couple of years ago. She’d never heard of it and was shocked to find out diabetes is considered a common co-condition. In fact, 20-30 percent of people with diabetes can end up with EPI. EPI can cause a lot of discomfort and stomach issues – and health issues if left untreated. Of course, Dana jumped in, publishing a review of studies and now creating studies of her own. She’ll explain what she’s doing, why she needs your help, and more about this condition that doesn’t get much attention.
We have a monthly newsletter! Sign up today (no spam we promise)
July 5, 2024
In the News... Generic GLP-1, All-in-one sensor and infusion set, 365-day CGM and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The Eversense CGM could soon be approved for one year of continuous use, the first generic GLP-1 medication is launched, a new company tauts and all-in-one sensor and pump infusion set, a new diabetes accessory in the Roblox game, and more!
We have a monthly newsletter! Sign up today (no spam we promise)
June 21, 2024
Navigating the Ozempic & Mounjaro shortage - Advice from an endocrinologist
Medications like Ozempic and Mounjaro have fundamentally changed the way diabetes is treated. But even if your doctor writes the prescription and your insurance company covers it, getting your hands on the medication is getting harder and harder. We’re talking about what to do if you’re having trouble here – tips if you have to start and stop – and ways some have found to get their hands on the injections.
We have a monthly newsletter! Sign up today (no spam we promise)
June 21, 2024
In the news.. Insulin pen shortage, Omnipod 5 update, once-weekly insulin approved in Canada, and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: South Africa runs out of insulin pens – and why this could happen anywhere, once-weekly insulin is approved in Canada, update on Omnipod 5 with Dexcom G7 rollout, more older people are getting type 1 but more people are living longer with it, CGM at the Olympics and more!
We have a monthly newsletter! Sign up today (no spam we promise)
June 12, 2024
What is a diabetologist (and should you see one?)
Have you heard of a diabetologist? This is a newer specialty in the U-S that may help offset the lack of endocrinologists. Most people with type 2 see a general practitioner and the diabetology certification helps those doctors learn about the latest in diabetes care. We’ll talk about how to find one of these rare experts, why there could be more of them soon, and get advice about how to make the most of your diabetes visit to ANY doctor.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
We have a monthly newsletter! Sign up today (no spam we promise)
June 7, 2024
In the News... Dexcom to Apple Watch, Metformin during pregnancy, Mounjaro shortage update... and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom goes Direct to Watch in the US, Abbott gets FDA okay for its OTC CGM, new study about metformin during pregnancy, an update on semaglutides, JDRF changes its name, and more!
We have a monthly newsletter! Sign up today (no spam we promise)
May 29, 2024
Transforming Diabetes Care: GlucosePATH Makes Personalized Medication Recommendations
GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It was created by computer scientist Len Testa and endocrinologist Dr. Bradly Eilerman.
Len Testa is also co host of the fabulous Disney Dish podcast and the creator of Touring Plans the app and service of The Unofficial Guides to Walt Disney World, Disneyland and Disney Cruise Line. Testa is all about the math of theme parks – his guides are there to maximize the magic as he says – to make your waits shorter and save money – and it’s all based on calculations from his team.
Disney very recently made some changes to their Disability Access Services program – often referred to as a DAS pass at Disney World and Disney Land. We’re going to talk about why this happened, what it means for you, and what else is going on at Disney.
Note: this interview was taped BEFORE the changes took place.
More about Len Testa’s Touring Plans here
More about the DAS changes here
We’re also spending some time talking about a new service for doctors called Glucosepath and about a new surprising study about cortisol and diabetes. I’ll also explain how these two guests can talk about all of these issues..
Dr. Eilerman also talks about the Catalyst study which looks at people with type 2 diabetes and measures cortisol.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
May 15, 2024
Inside the class-action lawsuit against insulin pricing, with Attorney Steve Berman
This week, talking with one of the lawyers bringing a class-action lawsuit against the insulin companies.. a lawsuit that has been inching forward since 2017. It was set to be settled for 500-million dollars and a four year price cap, but then judge said no. Attorney Steve Berman will talk about that last minute surprise, why he’s still going forward, and what he needs now from the diabetes community. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
May 10, 2024
In the News.. T1D increasing in older adults, new iCGM designation, low BG prevention tested, and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: more older adults are being diagnosed with type 1 and people with T1D are living longer, Eversense gets iCGM designation, new drug to prevent low BG is being tested, Tandem diabetes app recall, and more!
May 1, 2024
Diabetes In The Hospital - What Patients Need To Know
We’re taking a close up look at hospital care when you have type 2 – from the people who grade the hospitals. 30% of patients admitted for acute care have diabetes. But many hospitals aren’t prepared or have staff trained to take care of this. My guests – from the watchdog group Leapfrog and from the ADA, will talk about what’s been doing right and how you can be better prepared if you need hospital care.
My guests this week are Leah Binder, President and CEO of the Leapfrog Group, Dr. Robert Gabbay, Chief Science & Medical Officer of the American Diabetes Association.
April 17, 2024
Dr. Nina Cash on becoming a Sports Illustrated Swimsuit Model at 57, with type 2 diabetes
We’re talking to a sports illustrated swimsuit model – who lives with type 2! Nina Cash is also in her late 50s – so being a swimsuit model wasn’t something she really thought was in the cards – she spent her career in education and retired as a University Dean. She’ll tell us the story of how the SI gig happened and why she’s park of the rookie class of this year’s big issue.
April 12, 2024
In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom launches direct-to-watch with the G7 in the UK and Ireland, more studies looking at heart benefits with Wegovy and diabetes, a new T1D study investigating an injectable to prevent overnight hypoglycemia, lobbying for Levimir, a ChatGPT diabetes diagnosis and more!
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
April 3, 2024
Diabetes Education is boring! This group wants YOUR input to make it better.
Diabetes education is boring. Right? Yeah educators think so too. So what can we do to make it better? We’re talking about a new effort to talk to people with diabetes and find out what works for you. I’m talking to Dr Bill Polonksy from the Behavioral Diabetes Institute
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Learn more about the study here
March 29, 2024
In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more!
Transcript and links here
March 20, 2024
Does every person with type 2 diabetes need a Continuous Glucose Monitor (CGM)?
This endocrinologist tries to have every single one of his patients use a CGM – that’s people with type 1 and type 2. Dr. Thomas Grace is going to explain the specific benefits he thinks people who don’t use insulin can get from a CGM, and shares a few studes just released at big diabetes conference, including those around using GLP-1s.. medications like Trulicty Victoza and Ozempic,
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
More information about the Glucose Measurement Indicator and Estimated A1C here:
https://www.healthline.com/health/diabetes/what-is-gmi#takeaway
Please visit our Sponsors & Partners – they help make the show possible!
March 15, 2024
In the News... ATTD updates, new CGMs, drops for diabetes eye disease, scholarships and more!
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The annual ATTD conference wraps up with news about CGMs, including new FDA approvals and a look at CGMs outside of the US, new eyedrops are being studied to treat diabetic eye disease and Beyond Type 1 opens applications for their annual Beyond Scholars.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
March 12, 2024
Navigating the Art of Medicine in the Age of AI with Dr. Allen Sussman
It’s pretty clear that the future of medicine will include artificial intelligence. It’s already part of doctor’s appointments, health data, and more. But balancing that machine learning high tech with a doctor’s personal touch is going to be tricky. This week, we’re talking about the art of medicine with endocrinologist and author Dr. Allen Sussman.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
March 6, 2024
Navigating Diabetes and Your Eye Health
What you need to know about diabetes and your eyes. I know, this one can make people nervous, but the most important thing to know is that treatments have changed A LOT and they are much more effective than you might think.
We’ll also define the most common type of diabetic eye complication, retinopathy.
The family I’m talking to is a father and daughter who both have type 1.. Randall and his daughter Emma Barker were diagnosed at the same age. And we are joined by Dr. Laura Hieronymus, Vice President of Health Care Programs for the American Diabetes Association.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
March 1, 2024
In the News... MicroGlucagon to speed up insulin, SGLT2 & false positive tests, FDA warns about non-invasive glucose monitors and more!
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: what is MicroGlucagon and how could it speed up existing rapid-acting insulin? SGLT2 medications may cause false positive alcohol tests, red light therapy for type 2 diabetes, research shows teens with type 2 might have a different kind of diabetes altogether, FDA warns against non-invasive glucose monitoring and more!
Feb 21, 2024
From Restrictive Diets to Realistic Solutions with Dr. Mike Roussell
What you eat is an important part of managing diabetes. By now, we all know being super restrictive doesn’t work, so let’s talk about some easier ways to work in more healthy foods without turning your life upside down.
My guest this week is Dr. Mike Roussell, an author and nutrition consultant who holds a degree in biochemistry and a PHD in nutrition.
We’ll also define insulin resistance and explain why this is an important part of understanding diabetes.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Feb 16, 2024
In the News.. Tandem Mobi released, surprising outcomes for type 2 surgery, exercise and diabetes studies, T1D at the Super Bowl, and more!
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Tandem announces it’s taking orders and starting to ship the Mobi pump, Insulet gets European approval for the Abbott Libre integration with Omnipod 5, new study looks at type 2 remission and gastric bypass surgery, one type of medication seems to do a much better job preventing kidney stones in people with type 2, big new grant to look at exercise and type 1 and a look back at diabetes at the Super Bowl.
Find out more about Moms’ Night Out
Feb 14, 2024
A new CGM made for people with type 2 - Learn about Dexcom's Stelo
Dexcom is planning a new CGM system called Stelo, aimed at people with type 2 diabetes who don’t use insulin. This week, we’re talking to the Chief Operating Officer Jake Leach all about this.
Dexcom is the leading CGM used with insulin pumps, so this is an interesting new direction for them. What’s the difference between this device and those made for people who dose insulin? plus a lot more information about their existing product lines.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Our previous episodes with Dexcom here: https://diabetes-connections.com/?s=dexcom
Feb 7, 2024
Need a CGM? Ask your pharmacist. A new pilot program aims to improve access
Getting a CGM is, more and more, becoming a routine part of a diabetes diagnosis. But figuring out if your insurance will pay can be anything but routine. A new pilot program is recruiting pharmacists to be a big part of this process, helping educate patients about their options, even writing prescriptions. Plus, with all the talk about CGM, you may have heard about time in range. What is that and why is it inching out A1C as a gold standard measurement.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Feb 2, 2024
In the News.. weight loss & cancer study for T2D, new pump submitted, Summer Olympic hopeful with T1D and more!
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a look at how weight loss might lower cancer risk in people with type 2, a new study that says BG spikes are good(?!), Modular Medical submits a new insulin pump the FDA, another look at COVID-19’s effects on people with diabetes, a marathoner with type 1 heads to the last trial for this summer’s Olympics, and more!
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Jan 31, 2024
Adjusting to a Type 2 Diabetes Diagnosis PR Pro Matt Friedman
My guest is Matt Friedman, an expert in public relations who lives with type 2 – we get his take on what’s going on in PR these days – with social media, crisis control, and even CHatGPT and AI – and of course we’ll talk about diabetes, and the bone Matt has to pick with restaurants.
I love talking abou technology and the majority of these episodes will be about management tools and techniques, but I’ve also learned that personal stories – talking to people JUST living with diabetes – can be extremely helpful. This episode is one of those people focused ones.
We’ll also talk about carbs – why do people with diabetes measure carbohydrates and not sugar?
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Jan 24, 2024
Insulin Use with Type 2 Diabetes: Navigating Solutions, Avoiding Stigma
Let’s talk about using insulin. For some, that can feel like a huge failure or that they have the bad type of diabetes. But sometimes, diet and exercise isn’t enough to manage type 2 diabetes. My guest this week is Dr. Arthi Thangudu and she’s going to talk about how she approaches these conversations with her patients and some of the newer options out there for administering insulin.
Also this week, as long as we’re talking about insulin, we’ll define the different kinds.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Jan 19, 2024
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Vertex pauses their stem cell transplantation trials after a patient death, spray insulin is tested, learning more about Dexcom’s sensor for type 2, measuring A1C through menstrual blood and more!
Jan 16, 2024
When you get a diabetes diagnosis, eating well is usually at the top of the “to-do” list. But then you get home and look around the kitchen and – let’s face it – most of us aren’t sure where to start. What’s easy to cook that will taste good? What will my family actually eat?
This week I’m talking to Chef Robert Lewis, who calls himself the happy diabetic. He lives with type 2 and he’ll explain why he started off very unhappy! And what changed..
Also this week, we’re explaining the term post prandial blood sugar. What does it mean and why is your doctor so concerned about it?
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Jan 16, 2024
This time of year diets are the center of a lot of conversations. So when I heard WeightWatchers was specifically offering something for people with diabetes, I wanted to learn more. WeightWatchers is teaming up with Abbott to use the Freestyle Libe CGM as part of their newest program. What does really mean for people with type 2? What are they offering and will it make a difference? I’m talking to the Chief Science Officer of WeightWatchers and Chief Medical Officer of Abbott.
Also this week, why is the fasting blood glucose test so important? And what are it’s limitations?
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: infusion set recall, update on ViaCyte stem cell research, a few new studies look at sleep and diabetes, actual clinical research into cinnamon for type 1 and lots more. Links & transcript below Find out more about Moms’ Night Out Please visit our Sponsors & Partners – they help make the show possible! Edgepark Medical Supplies — We will be starting a newsletter soon. Sign up today (no spam we promise) Here’s where to find us: Facebook (Group) Facebook (Page) Instagram Threads
GEM is being called a radical new way to treat diabetes and The National Institutes of Health is giving millions to study it. We’re going to talk about Glucose Everyday Matters (also called Glucose Excursion Minimization) with Dr. Daniel Cox, the UVA researcher who lives with type 2 and developed it. Let’s also talk about insulin resistance. You’ve probably heard the term, but what does it mean? Can you change it? Should you? This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about insulin resistance here More about GEMS here
NOV 26, 2023
This week’s guest had such a strong family history of diabetes that she decided gastric bypass surgery was the right option for her. That was more than ten years ago – how is Ramona Holloway – and her diabetes – doing now? Plus, you’ve probably heard of a CGM. How does it work? Is there more than one kind? This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More information about CGM here: The
NOV 17, 2023
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Novo Nordisk will discontinue Levemir by the end of 2024, Tandem begins limited launch of software updates that will include Dexcom’s G7, Beta Bionics iLet pump will be covered until some pharmacy plans, and lots more! Links and transcript below Find out more about Moms’ Night Out Please visit our Sponsors & Partners – they help make the show possible! Edgepark Medical Supplies The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our
NOV 15, 2023
Do you know your rights with diabetes? Our guest this week is John Griffin, a trial lawyer with more than 30 years of advocating in and out of the courtroom. He lives with type 2 himself – this is an eye opening and useful conversation. Griffin served as National Chair of the Board of the American Diabetes Association in 2011, and is the former Chair of the Association’s Legislative and Regulatory Subcommittee. Also, if you’ve been given a blood glucose meter you probably know how to use it, but do you know how it works? We’ll explain the chemistry going on here This podcast is not intended as
NOV 8, 2023
Professional golfer Ken Duke plays on the PGA Champions Tour; you may have seen him win this summer. You may not know he lives with type 2. He shares how he was diagnosed, how he manages on the tour, and I ask for some advice for my golf game. Plus, Metformin is probably the most prescribed diabetes drug. What is it? How does it work? This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. The information explaining Metformin comes from DiaTribe Please visit our Sponsors & Partners – they help make the show
NOV 3, 2023
It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new study looks at pancreatic exocrine-endocrine “crosstalk,” weekly basal for T1D moves forward, a Chinese company gets European approval for its CGM, a look at air pollution as a cause of T2D, lots of info and advocacy for Diabetes Awareness Month including some movies and documentaries.
NOV 1, 2023
Medications like Ozempic, Wegovy and Mounjaro are getting a lot of attention. What are they? How do they work to help people with diabetes and should you think about taking one? Plus we’ll break down the difference between type 1 and type 2. I get this question a lot – so let’s explain it. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. — The information explaining the difference between type 1 and type 2 comes from the Joslin Center for Diabetes — Please visit our Sponsors & Partners – they help make the show possible! Learn
NOV 1, 2023
Welcome to our first episode! Here’s what we’re talking about: What IS an A1C? What you need to know about this all-important number. My guest is a sports photographer and journalist. We’re going to talk about what it takes to do that job and how he was diagnosed with diabetes after a tough run in with the Texas heat.. And hey this is our first episode – we’ll get to know each other a little bit. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. — A1C information from: The Mayo Clinic and the American Diabetes Assocation More about
OCT 6, 2023
No nagging, no lecturing. Just good information about what’s new for people with type 2 diabetes. Coming soon!
